VIR
Vir Biotechnology Inc.
$4.94
-$0.10(-1.98%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$616.79M
Volume
1.68M
52W Range
$4.16 - $14.45
Target Price
$17.63
Order:
Income Statement
| Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | $711.0K | $67.2M | $1.1B | $1.6B | $86.2M | $74.2M | ||
| Total Revenue | $8.1M | $67.2M | $1.1B | $1.6B | $86.2M | $63.7M | ||
| COST OF GOODS SOLD | ||||||||
| Cost of Revenue | -- | -- | $65.9M | $146.3M | $2.8M | $845.0K | ||
| GROSS PROFIT | ||||||||
| Gross Profit | $8.1M | $67.2M | $1.0B | $1.4B | $83.4M | $62.9M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $186.1M | $373.3M | $674.7M | $636.4M | $754.2M | $625.5M | ||
| Research & Development | $148.5M | $302.4M | $448.0M | $474.6M | $579.7M | $506.5M | ||
| Research Expense | $148.5M | $302.4M | $448.0M | $474.6M | $579.7M | $506.5M | ||
| Selling, General & Administrative | $37.6M | $70.9M | $226.7M | $161.8M | $174.4M | $119.0M | ||
| Selling & Marketing Expenses | -- | -- | $65.9M | -- | -- | -- | ||
| General & Administrative Expenses | $37.6M | $70.9M | $160.8M | $161.8M | $174.4M | $119.0M | ||
| Salaries & Wages | -- | -- | -- | $102.1M | $111.3M | $78.5M | ||
| Depreciation & Amortization | $3.3M | $4.4M | $5.3M | $6.3M | $19.5M | $14.6M | ||
| Depreciation & Amortization | $3.3M | $4.4M | $5.3M | $6.3M | $19.5M | $14.6M | ||
| Amortization | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | $16.9M | ||
| Other Operating Expenses | $-1.8M | $-2.7M | $-2.6M | $-3.2M | $-2.9M | $-2.4M | ||
| OPERATING INCOME | ||||||||
| Operating income | $-178.0M | $-297.0M | $420.8M | $833.1M | $-684.3M | $-587.2M | ||
| EBITDA | $-170.2M | $-291.5M | $426.6M | $761.1M | $-608.7M | $-508.5M | ||
| NON-OPERATING ITEMS | ||||||||
| Intinc | $8.5M | -- | -- | -- | $87.0M | $71.8M | ||
| Net Non-Operating Interest Income/Expense | $8.5M | -- | -- | $-28.1M | $87.0M | $71.8M | ||
| Other Income/Expense | $-10.8M | $-7.5M | $-137.4M | $-106.9M | $30.9M | $7.7M | ||
| Other Special Charges | $10.8M | $7.5M | $-651.0K | $32.4M | $-9.0M | $-2.2M | ||
| SPECIAL ITEMS | ||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | $13.6M | $35.0M | ||
| Special Income Charges | -- | $-832.0K | -- | -- | $-13.6M | $-35.0M | ||
| Impairment of Capital Assets | -- | $832.0K | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-174.5M | $-297.0M | $420.8M | $754.3M | $-628.2M | $-523.1M | ||
| Pre-Tax Income | $-174.5M | $-298.6M | $549.8M | $754.3M | $-628.2M | $-523.1M | ||
| INCOME TAX | ||||||||
| Tax Provision | $154.0K | $54.0K | $21.2M | $238.4M | $-13.1M | $-1.1M | ||
| NET INCOME | ||||||||
| Net Income | $-174.7M | $-298.7M | $528.6M | $515.8M | $-615.1M | $-522.0M | ||
| Net Income (Continuing Operations) | $-174.7M | $-298.7M | $528.6M | $515.8M | $-615.1M | $-522.0M | ||
| Net Income (Discontinued Operations) | $-174.7M | $-298.7M | $528.6M | $515.8M | $-615.1M | $-522.0M | ||
| Net Income (Common Stockholders) | $-174.7M | $-298.7M | $528.6M | $515.8M | $-615.1M | $-522.0M | ||
| TOTALS | ||||||||
| Total Expenses | $186.1M | $373.3M | $740.5M | $782.7M | $756.9M | $626.4M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $30.3M | $119.2M | $129.9M | $132.6M | $134.1M | $136.2M | ||
| Average Shares Outstanding (Diluted) | $30.3M | -- | $133.4M | $134.8M | $134.1M | $136.2M | ||
| Shares Outstanding | $109.8M | $127.8M | $132.3M | $133.5M | $135.0M | $137.1M | ||
| Basic EPS | $-5.76 | $-2.51 | $4.07 | $3.89 | $-4.59 | $-3.83 | ||
| Basic EPS (Continuing Operations) | $-5.76 | $-2.51 | $4.07 | $3.89 | $-4.59 | $-3.83 | ||
| Diluted EPS | $-5.76 | $-2.51 | $3.96 | $3.83 | $-4.59 | $-3.83 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $3.96 | $3.83 | $-4.59 | $-3.83 | ||
| OTHER METRICS | ||||||||
| Gain On Sale Of P P E | -- | -- | $4.8M | -- | -- | -- | ||
| Interest Expense Operating | -- | -- | $65.9M | -- | -- | -- | ||
| Minority Interests | -- | -- | -- | -- | $56.0K | -- | ||
| Other Gand A | $37.6M | $70.9M | $160.8M | $161.8M | $174.4M | $119.0M | ||
| Restruct | -- | -- | -- | -- | $13.6M | $35.0M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VIR | $4.94 | -2.0% | 1.68M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |